Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Rosa Morla"'
Autor:
Raul Castellanos-Moreira, Sebastian C. Rodriguez-Garcia, Sonia Cabrera-Villalba, María José Gomara, Georgina Salvador, Virginia Ruiz-Esquide, Julio Ramirez, Jose Inciarte-Mundo, Rosa Morla, Cristina Garcia-Moreno, Andrea Cuervo, Jose A. Gómez-Puerta, Juan D. Cañete, Isabel Haro, Raimon Sanmarti
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 12 (2020)
Background: A restricted response against citrullinated peptides/proteins, with less isotype usage, has been found in palindromic rheumatism (PR) in comparison with rheumatoid arthritis (RA). We hypothesized that this different antibody response may
Externí odkaz:
https://doaj.org/article/f593e42302c5492ab4063abec29d9032
Autor:
Beatriz Frade-Sosa, Andrés Ponce, Estíbaliz Ruiz-Ortiz, Noemí De Moner, María J. Gómara, Ana Belén Azuaga, Juan C. Sarmiento-Monroy, Rosa Morlà, Virginia Ruiz-Esquide, Laura Macías, Nuria Sapena, Lola Tobalina, Julio Ramirez, Juan D. Cañete, Jordi Yague, Josep M. Auge, José A. Gomez-Puerta, Odette Viñas, Isabel Haro, Raimon Sanmarti
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 3, Pp 501-521 (2024)
Abstract Introduction This study assesses the accuracy of neutrophil activation markers, including neutrophil extracellular traps (NETs) and calprotectin, as biomarkers of disease activity in patients with established rheumatoid arthritis (RA). We al
Externí odkaz:
https://doaj.org/article/7fab13c72a6349acbfaf5c3e8818d3bb
Autor:
Beatriz Frade-Sosa, Andrés Ponce, José Inciarte-Mundo, Rosa Morlà, Viginia Ruiz-Esquide, Laura Macías, Ana Belen Azuaga, Julio Ramirez, Juan D. Cañete, Jordi Yague, Josep M. Auge, José A. Gomez-Puerta, Raimon Sanmarti
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 14 (2022)
Objectives: To analyse the accuracy of plasma calprotectin in patients with rheumatoid arthritis (RA) receiving monoclonal antibodies against IL-6 receptors (anti-rIL-6) or JAK inhibitors (JAKis) in detecting ultrasound (US) synovitis and compare it
Externí odkaz:
https://doaj.org/article/cd75b5f089f143dca089d47c79eef595
Publikováno v:
Clinical Infectious Diseases. 20:1435-1437
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b864d8af6240b89cefee95d07269a6e
https://doi.org/10.1093/clinids/20.5.1435
https://doi.org/10.1093/clinids/20.5.1435
Autor:
Mireia Moreno, Jordi Gratacós, Vicenç Torrente-Segarra, Raimon Sanmarti, Rosa Morlà, Caridad Pontes, Maria Llop, Xavier Juanola, REMINEA study Group
Publikováno v:
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-6 (2019)
Abstract Background Recent data suggest that anti-TNF doses can be reduced in ankylosing spondylitis (AS) patients. Some authors even propose withdrawing treatment in patients in clinical remission; however, at present there is no evidence to support
Externí odkaz:
https://doaj.org/article/d53a91c0bb4e4ba7b983add611299b6f
Autor:
Andrés Ponce, Beatriz Frade-Sosa, Juan C. Sarmiento-Monroy, Nuria Sapena, Julio Ramírez, Ana Belén Azuaga, Rosa Morlà, Virginia Ruiz-Esquide, Juan D. Cañete, Raimon Sanmartí, José A. Gómez-Puerta
Publikováno v:
Diagnostics, Vol 12, Iss 8, p 1961 (2022)
Immune checkpoint inhibitor (ICI)-induced arthritis is an increasingly recognized adverse event in patients with oncologic disease during immunotherapy. Four patterns are well described, including rheumatoid arthritis (RA)-like, polymyalgia rheumatic
Externí odkaz:
https://doaj.org/article/46cf5ac396c04b55a84b418e31f0c07d
Autor:
Raimon Sanmartí, Beatriz Frade-Sosa, Rosa Morlà, Raul Castellanos-Moreira, Sonia Cabrera-Villalba, Julio Ramirez, Georgina Salvador, Isabel Haro, Juan D. Cañete
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Palindromic rheumatism (PR), a unique clinical entity, has a characteristic clinical presentation with a relapsing/remitting course. It is established that most patients with PR evolve to chronic disease, of which rheumatoid arthritis (RA) is by far
Externí odkaz:
https://doaj.org/article/51eac56a54db44a3894a81e337c753f5
Autor:
Beatriz Frade-Sosa, Andrés Ponce, Virginia Ruiz-Esquide, Maria Jesús García-Yébenes, Rosa Morlá, Nuria Sapena, Julio Ramirez, Ana Belen Azuaga, Juan Camilo Sarmiento, Juan D. Cañete, Jose A. Gomez-Puerta, Raimon Sanmarti
Publikováno v:
Diagnostics, Vol 12, Iss 1, p 182 (2022)
Background: We examined whether high-sensitivity CRP (hsCRP) reflected the inflammatory disease status evaluated by clinical and ultrasound (US) parameters in RA patients receiving IL-6 receptor antibodies (anti-IL-6R) or JAK inhibitors (JAKi). Metho
Externí odkaz:
https://doaj.org/article/02369a30c17c4105a6e0126965925d97